Ungvari Z, Koller A
Department of Pathophysiology, Semmelweis University of Medicine, Budapest, Hungary.
Microcirculation. 2001 Aug;8(4):265-74. doi: 10.1038/sj/mn/7800080.
To characterize the role of K(+) channels, the cytochrome P-450 (CYP) metabolite 5,6-EET, and gap junctions in modulation of arteriolar myogenic tone by a non-nitric oxide nonprostaglandin mediator, termed "endothelium-dependent hyperpolarizing factor" (EDHF), released to acetylcholine (ACh) in skeletal muscle arterioles.
In isolated rat gracilis arterioles, simultaneous changes in smooth muscle (aSM) Ca(2+) (assessed by changes in fura-2 ratiometric signal, R(Ca)) and diameter were measured in response to ACh in the presence of indomethacin and L-NAME.
ACh, the K(ATP) channel opener pinacidil, and the Ca(2+) channel inhibitor verapamil elicited comparable decreases in aSM Ca(2+) (max.: -32 +/- 3%, 29 +/- 3%, and -30 +/- 3%, respectively) and arteriolar dilations (max.: 90 +/- 4%, 96 +/- 2%, and 95 +/- 2%, respectively). ACh-induced responses were inhibited by KCl-depolarization, K(Ca) channel blockers (TEA, charybdotoxin), or gap junction inhibitors (18alpha-glycyrrhetinic acid, hyperosmolar sucrose). The K(ATP) channel inhibitor glibenclamide, the K(IR) channel inhibitor barium chloride, or the CYP inhibitor 17-octadecynoic acid (ODYA) were without effect. The putative EDHF analogue 5,6-EET elicited constrictions in the presence of the endothelium that could be prevented by indomethacin or a TxA(2) receptor antagonist, whereas in the absence of the endothelium, EDHF elicited only small, charybdotoxin-insensitive decreases in aSM R(Ca) and dilations (max.: -8 +/- 2% and 27 +/- 4%, respectively).
In skeletal muscle arterioles, EDHF 1) substantially and rapidly reduces myogenic tone by decreasing aSM Ca(2+) via opening K(Ca) channels, 2) it is unlikely to be 5,6-EET or other CYP metabolites, but 3) requires functional gap junctions.
研究钾离子通道、细胞色素P - 450(CYP)代谢产物5,6 -环氧二十碳三烯酸(5,6 - EET)和缝隙连接在一种非一氧化氮非前列腺素介质(称为“内皮依赖性超极化因子”(EDHF))调节骨骼肌小动脉肌源性张力中的作用,该介质由乙酰胆碱(ACh)释放产生。
在离体大鼠股薄肌小动脉中,于吲哚美辛和L - 硝基精氨酸甲酯(L - NAME)存在的情况下,测量对ACh反应时平滑肌(aSM)细胞内钙离子浓度([Ca²⁺]i,通过fura - 2比率信号变化R(Ca)评估)和直径的同步变化。
ACh、钾离子ATP通道开放剂吡那地尔和钙离子通道抑制剂维拉帕米引起aSM [Ca²⁺]i类似程度的降低(最大值分别为:-32±3%、-29±3%和-30±3%)以及小动脉扩张(最大值分别为:90±4%、96±2%和95±2%)。ACh诱导的反应被氯化钾去极化、钾离子钙通道阻滞剂(四乙铵、蝎毒素)或缝隙连接抑制剂(18α - 甘草次酸、高渗蔗糖)抑制。钾离子ATP通道抑制剂格列本脲、内向整流钾通道抑制剂氯化钡或CYP抑制剂17 - 十八炔酸(ODYA)无作用。推测的EDHF类似物5,6 - EET在有内皮存在时引起收缩,吲哚美辛或血栓素A₂(TxA₂)受体拮抗剂可预防这种收缩,而在内皮不存在时,EDHF仅引起aSM R(Ca)微小的、对蝎毒素不敏感的降低和扩张(最大值分别为:-8±2%和27±4%)。
在骨骼肌小动脉中,EDHF 1)通过开放钾离子钙通道降低aSM [Ca²⁺]i,从而显著且快速地降低肌源性张力;2)不太可能是5,6 - EET或其他CYP代谢产物;但3)需要功能性缝隙连接。